Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | YRDC |
| Upstream (Parents) |
|---|
| (<<) CRKL → YRDC |
| (<<) DHX9 → YRDC |
| (<<) ELOVL1 → YRDC |
| (<<) HSPC159 → YRDC |
| (<<) MAT2A → YRDC |
| (<<) MYC → YRDC |
| (<<) RDX → YRDC |
| (<<) RECK → YRDC |
| (<<) RRAS2 → YRDC |
| (<<) SOS2 → YRDC |
| (<<) SPAG5 → YRDC |
| (<<) STAT6 → YRDC |
| (<<) SYK → YRDC |
| (<<) UBE2C → YRDC |
| Downstream (Children) |
|---|
| YRDC → ADORA2B (>>) |
| YRDC → BDH1 (>>) |
| YRDC → CALM3 (>>) |
| YRDC → CCNB1 (>>) |
| YRDC → CCNB2 (>>) |
| YRDC → CDK5 (>>) |
| YRDC → CTPS (>>) |
| YRDC → DLAT (>>) |
| YRDC → DPH2 (>>) |
| YRDC → EIF4E (>>) |
| YRDC → GRPEL1 (>>) |
| YRDC → IL1R1 (>>) |
| YRDC → LBX1 (>>) |
| YRDC → MAP3K9 (>>) |
| YRDC → MT1G (>>) |
| YRDC → MYCN (>>) |
| YRDC → NMU (>>) |
| YRDC → PIK3R3 (>>) |
| YRDC → PKIA (>>) |
| YRDC → PLA2R1 (>>) |
| YRDC → PLK1 (>>) |
| YRDC → POP1 (>>) |
| YRDC → PTPMT1 (>>) |
| YRDC → RPL23A (>>) |
| YRDC → RRP9 (>>) |
| YRDC → SEH1L (>>) |
| YRDC → TM4SF1 (>>) |
| YRDC → UBQLN1 (>>) |
| YRDC → WNT4 (>>) |
| YRDC → ZNF575 (>>) |
